The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial
Open accessAbstract
AIM: N-3 fatty acids, especially eicosapentaenoic acid (EPA), may possess anticachectic properties. This trial compared a protein and energy dense supplement enriched with n-3 fatty acids and antioxidants (experimental: E) with an isocaloric isonitrogenous control supplement (C) for their effects on weight, lean body mass (LBM), dietary intake, and quality of life in cachectic patients with advanced pancreatic cancer. METHODS: A total of 200 patients (95 E; 105 C) were randomised to consume two cans/day of the E or C supplement (480 ml, 620 kcal, 32 g protein +/- 2.2 g EPA) for eight weeks in a multicentre, randomised, double blind trial. RESULTS: At enrolment, patients' mean rate of weight loss was 3.3 kg/month. Intake of the supplements (E or C) was below the recommended dose (2 cans/day) and averaged 1.4 cans/day. Over eight weeks, patients in both groups stopped losing weight (delta weight E: -0.25 kg/month versus C: -0.37 kg/month; p = 0.74) and LBM (Delta LBM E: +0.27 kg/month versus C: +0.12 kg/month; p = 0.88) to an equal degree (change from baseline E and C, p<0.001). In view of evident non-compliance in both E and C groups, correlation analyses were undertaken to examine for potential dose-response relationships. E patients demonstrated significant correlations between their supplement intake and weight gain (r = 0.50, p<0.001) and increase in LBM (r = 0.33, p = 0.036). Such correlations were not statistically significant in C patients. The relationship of supplement intake with change in LBM was significantly different between E and C patients (p = 0.043). Increased plasma EPA levels in the E group were associated with weight and LBM gain (r = 0.50, p<0.001; r = 0.51, p = 0.001). Weight gain was associated with improved quality of life (p<0.01) only in the E group. CONCLUSION: Intention to treat group comparisons indicated that at the mean dose taken, enrichment with n-3 fatty acids did not provide a therapeutic advantage and that both supplements were equally effective in arresting weight loss. Post hoc dose-response analysis suggests that if taken in sufficient quantity, only the n-3 fatty acid enriched energy and protein dense supplement results in net gain of weight, lean tissue, and improved quality of life. Further trials are required to examine the potential role of n-3 enriched supplements in the treatment of cancer cachexia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Principles of nutritional assessment
(1990) · Choice Reviews Online · doi:10.5860/choice.27-6362 · Cited by 2,765
Prognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354
Endres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W. M., Cannon, J. G., Rogers, T. S., Klempner, M. S., Weber, P. C., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902023200501 · Cited by 1,910
Causes of death in cancer patients
Inagaki, J., Rodriguez, V., & Bodey, G. P. (1974) · Cancer · doi:10.1002/1097-0142(197402)33:2<568::aid-cncr2820330236>3.0.co;2-2 · Cited by 601
Barber, M. D., Ross, J. A., Voss, A. C., Tisdale, M. J., & Fearon, K. C. H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690654 · Cited by 459
Self-citationBramhall, S. R., Rosemurgy, A., Brown, P. D., Bowry, C., Buckels, J. A. C., & for the Marimastat Pancreatic Cancer Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3447 · Cited by 438
Characterization of a cancer cachectic factor
Todorov, P., Cariuk, P., McDevitt, T., Coles, B., Fearon, K., & Tisdale, M. (1996) · Nature · doi:10.1038/379739a0 · Cited by 437
Self-citationRelationship between total body water and surface area in normal and obese subjects
Hume, R., & Weyers, E. (1971) · Journal of Clinical Pathology · doi:10.1136/jcp.24.3.234 · Cited by 377
Gogos, C. A., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, N. C., & Kalfarentzos, F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980115)82:2<403::aid-cncr21>3.0.co;2-1 · Cited by 311
Wigmore, S. J., Ross, J. A., Stuart Falconer, J., Plester, C. E., Tisdale, M. J., Carter, D. C., & Ch Fearon, K. (1996) · Nutrition · doi:10.1016/0899-9007(95)00078-x · Cited by 297
Effect of Oral Eicosapentaenoic Acid on Weight Loss in Patients With Pancreatic Cancer
Wigmore, S. J., Barber, M. D., Ross, J. A., Tisdale, M. J., & Fearon, K. C. H. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3602_6 · Cited by 275
Self-citationOvesen, L., Allingstrup, L., Hannibal, J., Mortensen, E. L., & Hansen, O. P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.2043 · Cited by 271
Changes in nutritional status associated with unresectable pancreatic cancer
Wigmore, S., Plester, C., Richardson, R., & Fearon, K. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.17 · Cited by 247
Self-citationWhitehouse, A., Smith, H. J., Drake, J. L., & Tisdale, M. J. (2001) · PubMed · Cited by 226
Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover.
Beck, S., Smith, K. L., & Tisdale, M. J. (1991) · PubMed · Cited by 216
Grimble, R. F., Howell, W. M., O’Reilly, G., Turner, S. J., Markovic, O., Hirrell, S., East, J. M., & Calder, P. C. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.454 · Cited by 213
Wigmore, S. J., Fearon, K. C. H., Maingay, J. P., & Ross, J. A. (1997) · Clinical Science · doi:10.1042/cs0920215 · Cited by 195
Self-citationEvans, W. K., Nixon, D. W., Daly, J. M., Ellenberg, S. S., Gardner, L., Wolfe, E., Shepherd, F. A., Feld, R., Gralla, R., & Fine, S. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.113 · Cited by 186
Wigmore, S. J., Ross, J. A., Falconer, J. S., Plester, C. E., Tisdale, M. J., Carter, D. C., & Fearon, K. C. (1996) · Nutrition · doi:10.1016/0899-9007(96)90014-3 · Cited by 130
Self-citationHannan, W. J., Cowen, S. J., Plester, C. E., Fearon, K. C. H., & Debeau, A. (1995) · Clinical Science · doi:10.1042/cs0890651 · Cited by 121
Self-citationSimons, J. P., Aaronson, N. K., Vansteenkiste, J., ten Velde, G. P. M., Muller, M. J., Drenth, B. M. H., Erdkamp, F., Cobben, E. G., Schoon, E. J., Smeets, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1077 · Cited by 113
Fearon, K. C. H., Barber, M. D., & Moses, A. G. W. (2001) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30088-7 · Cited by 65
Self-citationLeeuwen, S. D. Z.-V., van der Heijden, M. S., Rietveld, T., et al. (2002) · Clinical Nutrition · doi:10.1054/clnu.2001.0530 · Cited by 62
Johnson, C. D., Puntis, M. C. A., Davidson, N. G. P., Todd, S., & Bryce, R. P. (2001) · British journal of surgery · doi:10.1046/j.0007-1323.2001.01770.x · Cited by 45
Validation of the Measurement of Body Composition from Whole Body Bioelectric Impedance
Shizgal, H. M. (1990) · Transfusion Medicine and Hemotherapy · doi:10.1159/000222559 · Cited by 44
Methods and validity of dietary assessments in four Scandinavian populations
Bingham, S. A., Wiggins, H. S., Englyst, H. N., Seppänen, R., Helms, P., Strand, R., Burton, R., J⊘rgensen, I. M., Poulsen, L., Pærregaard, A., et al. (1982) · Nutrition and Cancer · doi:10.1080/01635588209513735 · Cited by 30
Cited by
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
ESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
Self-citationBaracos, V. E., Martin, L., Korc, M., Guttridge, D. C., & Fearon, K. C. H. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.105 · Cited by 1,738
Self-citationTisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,192
Prado, C. M. M., Baracos, V. E., McCargar, L. J., Reiman, T., Mourtzakis, M., Tonkin, K., Mackey, J. R., Koski, S., Pituskin, E., & Sawyer, M. B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2242 · Cited by 1,104
Metadata
- Authors
- Fearon, K. C. H.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2003-10-01
- Volume
- 52
- Issue
- 10
- Pages
- 1479-1486
- ISSN
- 0017-5749 (ISSN-L)
- OpenAlex
- W2109956558
- Cited by
- 603
- References
- 27
- FWCI
- 19.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.